Insider Transactions in Q2 2024 at Eliem Therapeutics, Inc. (ELYM)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2024
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
13,008,546
+30.34%
|
$39,025,638
$3.84 P/Share
|
|
Jun 27
2024
|
Ra Capital Management, L.P. |
BUY
Grant, award, or other acquisition
|
Indirect |
5,259,872
+35.92%
|
-
|
|
Jun 27
2024
|
Stephen Basil Thomas |
BUY
Grant, award, or other acquisition
|
Direct |
103,907
+50.0%
|
-
|
|
Jun 20
2024
|
Emily Pimblett CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,245
-24.9%
|
$8,715
$7.21 P/Share
|
|
Jun 18
2024
|
Emily Pimblett CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
-
|
|
Apr 05
2024
|
Valerie Morisset EVP, R&D AND CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,847
+3.41%
|
-
|